Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system (Q38100285)

28 August 2017

Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system (English)

1 reference

Jennifer L Wilkinson-Berka

28 August 2017

0 references

series ordinal

4

1 reference

28 August 2017

Devy Deliyanti

3

0 references

Robert E Widdop

object named as

Robert E Widdop

series ordinal

2

0 references

author name string

Claudia A McCarthy

series ordinal

1

1 reference

28 August 2017

1 August 2013

1 reference

Clinical and Experimental Pharmacology and Physiology

28 August 2017

1 reference

28 August 2017

40

1 reference

28 August 2017

8

1 reference

28 August 2017

571-579

1 reference

Microglial activation and chronic neurodegeneration

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Repertoire of microglial and macrophage responses after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Turnover of resident microglia in the normal adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

History of innate immunity in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Neuroprotective and toxic changes in microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Potential role of microglia in retinal blood vessel formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

SDF-1/CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Scavenger function of resident autofluorescent perivascular macrophages and their contribution to the maintenance of the blood-retinal barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglial activation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Debris clearance by microglia: an essential link between degeneration and regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Current update on retinopathy of prematurity: screening and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Trophic macrophages in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglial activation in human diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Evidence of angiogenic vessels in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Neuroprotective effect of exogenous microglia in global brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

The importance of microglia in the development of the vasculature in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

AT2 receptors: functional relevance in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Angiotensin AT2 receptors: cardiovascular hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Liver angiotensinogen is the primary source of renal angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Astrocytes synthesize angiotensinogen in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

The brain renin-angiotensin system: location and physiological roles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Expression of angiotensin II and its receptors in the normal and hypoxic amoeboid microglial cells and murine BV-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

The retinal renin-angiotensin system: roles of angiotensin II and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Lower frequency of antidepressant use in patients on renin-angiotensin-aldosterone system modifying medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Brain microglial cytokines in neurogenic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Six commercially available angiotensin II AT1 receptor antibodies are non-specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Angiotensin II sustains brain inflammation in mice via TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Role of IL-6 in angiotensin II-induced retinal vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Extrarenal effects of aldosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Effect of angiotensin II type 2 receptor deletion in hematopoietic cells on brain ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12099

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12099

1 reference

28 August 2017

1 reference

PubMed ID

23601050